Development and Application of a Patient Group Engagement Prioritization Tool for Use in Medical Product Development Posted on July 3, 2020March 31, 2025 by Hannah Faulkner Development and Application of a Patient Group Engagement Prioritization Tool for Use in Medical Product Development
Determining the Suitability of Registries for Embedding Clinical Trials in the United States: A Project of the Clinical Trials Transformation Initiative Posted on June 22, 2020February 11, 2025 by Hannah Faulkner Determining the Suitability of Registries for Embedding Clinical Trials in the United States: A Project of the Clinical Trials Transformation Initiative
Consensus on Language for Advance Informed Consent in Health Care–Associated Pneumonia Clinical Trials Using a Delphi Process Posted on May 22, 2020October 4, 2024 by Hannah Faulkner Consensus on Language for Advance Informed Consent in Health Care–Associated Pneumonia Clinical Trials Using a Delphi Process
Continued investigator engagement: Reasons principal investigators conduct multiple FDA-regulated drug trials Posted on March 7, 2020February 6, 2025 by Hannah Faulkner Continued investigator engagement: Reasons principal investigators conduct multiple FDA-regulated drug trials
Hospital-acquired Pneumonia and Ventilator-associated Pneumonia in Children: A Prospective Natural History and Case-Control Study Posted on March 2, 2020October 4, 2024 by Hannah Faulkner Hospital-acquired Pneumonia and Ventilator-associated Pneumonia in Children: A Prospective Natural History and Case-Control Study
Improving the Quality Conduct and Efficiency of Clinical Trials with Training: Recommendations for Preparedness and Qualification of Investigators and Delegates Posted on February 1, 2020February 6, 2025 by Hannah Faulkner Improving the Quality Conduct and Efficiency of Clinical Trials with Training: Recommendations for Preparedness and Qualification of Investigators and Delegates
Legal, Regulatory, and Practical Issues to Consider When Adopting Decentralized Clinical Trials: Recommendations From the Clinical Trials Transformation Initiative Posted on December 10, 2019February 7, 2025 by Hannah Faulkner Legal, Regulatory, and Practical Issues to Consider When Adopting Decentralized Clinical Trials: Recommendations From the Clinical Trials Transformation Initiative
Advancing the Use of Mobile Technologies in Clinical Trials: Recommendations from the Clinical Trials Transformation Initiative Posted on November 6, 2019February 11, 2025 by Hannah Faulkner Advancing the Use of Mobile Technologies in Clinical Trials: Recommendations from the Clinical Trials Transformation Initiative
Improving and sustaining the site investigator community: Recommendations from the Clinical Trials Transformation Initiative Posted on October 17, 2019February 6, 2025 by Hannah Faulkner Improving and sustaining the site investigator community: Recommendations from the Clinical Trials Transformation Initiative
Patient preferences for using mobile technologies in clinical trials Posted on September 11, 2019February 11, 2025 by Hannah Faulkner Patient preferences for using mobile technologies in clinical trials
